Fourpath Capital Management
MRK icon

Fourpath Capital Management’s Merck MRK Stock Holding History

Fourpath Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.97M Sell
13,553
-5,444
-29% -$752K 0.26% 69
2026
Q2 		$2.44M Buy
18,997
+577
+3% +$67.5K 0.32% 64
2026
Q1 		$2.22M Buy
18,420
+1,400
+8% +$162K 0.32% 59
2025
Q4 		$1.79M Buy
17,020
+2,399
+16% +$225K 0.25% 72
2025
Q3 		$1.23M Sell
14,621
-50
-0.3% -$4.12K 0.17% 88
2025
Q2 		$1.16M Hold
14,671
– – 0.18% 85
2025
Q1 		$1.32M Buy
14,671
+30
+0.2% +$2.8K 0.23% 80
2024
Q4 		$1.46M Sell
14,641
-101
-0.7% -$10.4K 0.27% 77
2024
Q3 		$1.67M Buy
14,742
+12,781
+652% +$1.52M 0.31% 70
2024
Q2 		$243K Sell
1,961
-46
-2% -$5.92K 0.18% 111
2024
Q1 		$265K Sell
2,007
-4
-0.2% -$493 0.18% 105
2023
Q4 		$219K Sell
2,011
-7
-0.3% -$727 0.15% 119
2023
Q3 		$208K Sell
2,018
-152
-7% -$16.4K 0.16% 110
2023
Q2 		$250K Sell
2,170
-32
-1% -$3.63K 0.3% 81
2023
Q1 		$234K Sell
2,202
-4,494
-67% -$485K 0.16% 114
2022
Q4 		$743K Sell
6,696
-3,344
-33% -$342K 0.54% 44
2022
Q3 		$865K Sell
10,040
-3,213
-24% -$287K 0.59% 42
2022
Q2 		$1.21M Sell
13,253
-1,919
-13% -$170K 0.75% 26
2022
Q1 		$1.24M Buy
15,172
+223
+1% +$17.6K 0.49% 38
2021
Q4 		$1.15M Buy
+14,949
New +$1.19M 0.44% 40

Other funds holding MRK

Smead Capital Management
Smead Capital Management Phoenix, Arizona $4.71B AUM 32.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Sarasin & Partners
Sarasin & Partners London, United Kingdom $8.93B AUM 11.81% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
Cacti Asset Management
Cacti Asset Management Atlanta, Georgia $1.89B AUM 58.55% 1-Year Est. Return

Fourpath Capital Management's MRK Position: Q3 2026 in Review

Fourpath Capital Management reduced its Merck (MRK) stake by 29% in Q3 2026, selling an estimated $752K and leaving 13,553 shares worth $1.97M. The position accounts for 0.26% of the portfolio, ranked #69.

Fourpath Capital Management first reported a position in MRK in Q4 2021 and has held it in 20 quarters since. The position peaked at $2.44M in Q2 2026. 957 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Fourpath Capital Management held 13,553 shares of Merck worth $1.97M as of Q3 2026.
  • Fourpath Capital Management sold 5,444 Merck shares in Q3 2026, an estimated $752K.
  • Merck made up 0.26% of Fourpath Capital Management's portfolio in Q3 2026, its #69 holding.
  • Fourpath Capital Management first reported a position in Merck in Q4 2021 and has held it in 20 quarters since.
  • Fourpath Capital Management's Merck position peaked at $2.44M in Q2 2026.
  • 957 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Fourpath Capital Management's 13F filing for Q3 2026, filed 19 Oct 2026.